…(11%), with two commencing or escalating biologics (infliximab, vedolizumab) and one receiving a non-biologic adjustment. No surgical refer…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 219 of 2459…minal pain–unspecified (46, 28%), functional constipation (36), irritable bowel syndrome (25), and rumination syndrome (18). Other less frequent present…
… altered microbial signatures in neuropsychiatric disorders. In schizophrenia, dysbiosis correlates with neuroinflammatory pathways, neurotra…
…access and delivery for people who present to the hospital with opioid overdose.…
…is. Based on observed synergy, the immunomodulatory drug (IMiD) lenalidomide was studied in more detail, exploring effects on Vγ9Vδ2-T cell …
…oimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).Methods We retrospectively analysed patients diagnosed wi…
…nfrequent (10% never; 34% rarely; 36% sometimes). Only 30% felt HCC guidelines provide useful recommendations on stopping surveilla…
…Background Ulcerative colitis is a refractory inflammatory bowel disease characterized by com…
…This model provides a practical tool for clinicians to stratify sepsis patients based on their individual risk of developing AGI, ther…
… antibody exerts significantly superior therapeutic efficacy to prednisolone and sulfasalazine in DSS-induced IBD-related intestinal fibrosi…
…ation and highlight that further investigation into the optimal UDCA dosing strategy is warranted.Abstract IDDF2026-ABS-0146 Figure …
…ng bile microbiome profiling as a promising adjunctive tool for PDAC diagnosis. Additionally, alterations in the bile microbiome wer…